Market Revenue Ion-Selective Clinical Lab Analyzers Industry | Page 2

Hence, such devices are used in clinical laboratories for precision. Overall, the ion-selective clinical lab analyzers
market growth is anticipated at a higher CAGR during the forecast period owing to rising popularity of ion-
selective electrodes.
The key driving factors responsible for the growth of ion-selective clinical lab analyzers industry include
commencing of appropriate treatment during emergencies, favourable disbursement and growing demand for
analysis of selective ions with patients on fluid therapy. However, the costs pertaining to this type of treatment
is likely to impede the market growth during the forecast period.
Browse Full Research Report @
https://www.millioninsights.com/industry-reports/ion-selective-clinical-lab-analyzers-market
On the basis of applications, the global ion-selective clinical lab analyzers market is segmented into biosensors
and blood gas analysis. On the basis of geographic segmentation, the global ion-selective clinical lab analyzers
market spans North America, Latin America, Europe, Asia-Pacific, Middle-East and Africa. North America
dominates the global market in terms of value and also due to high prevalence and early beginning of advanced
testing procedures.
Also, APAC, Latin America and Middle-East regions are anticipated to exhibit higher CAGR growth during the
forecast period due to inclination towards laboratory tests in these regions. The key players in the global ion-
selective clinical lab analyzers market include Abbott Point of Care, Microelectrodes Inc, Alfa Wassermann Inc,
F. Hoffmann-La Roche Ltd, Beckman Coulter Inc, Van London-Phoenix Company, and Thermo Fisher Scientific
Inc.
See More Reports of this Category by Million Insights @
https://www.millioninsights.com/industry/laboratory-equipment